Statement by FDA Commissioner Andrew C. von Eschenbach on Dr. Galson's Appointment
It is with great pride and admiration that I extend my congratulations to Dr. Steven Galson on his prestigious appointment to Acting Surgeon General, which begins October 1, 2007. As a Rear Admiral in the U.S. Public Health Service, Steven has a life-long commitment to the advancement of public health. Since joining FDA in 2001, he has provided exemplary leadership to one of FDA’s busiest centers—the Center for Drug Evaluation and Research. Because of his accomplishments, Americans have access to safer and more effective medical products than ever before. I know Steven will excel as our nation’s chief health educator and Americans will continue to benefit from his dedication to public service. As Steven transitions to his new role, I am appointing Dr. Janet Woodcock as Acting Center Director. Janet will retain her position as Deputy Commissioner and permanent Chief Medical Officer. In addition to assuming the day to day operational responsibilities of Center Director, she will work directly with me in immediately launching a national search for a permanent Center Director. I am indebted to her for one more demonstration of her dedicated service to the Agency, and I am extremely grateful for the support and commitment of every member of CDER in this effort.